Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure

ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans

(2017) José P. Guirao-Abad et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Candida albicans Chitin Increases Arginase-1 Activity in Human Macrophages, with an Impact on Macrophage Antimicrobial Functions

(2017) Jeanette Wagener et al.   mBio

Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota

(2016) Sarah Höfs et al.   JOURNAL OF MICROBIOLOGY

Echinocandin Resistance in Candida Species: a Review of Recent Developments

(2016) Nathan P. Wiederhold   Current Infectious Disease Reports

Antifungal drug resistance amongCandidaspecies: mechanisms and clinical impact

(2015) Maurizio Sanguinetti et al.   MYCOSES

Activation of stress signalling pathways enhances tolerance of fungi to chemical fungicides and antifungal proteins

(2014) Brigitte M. E. Hayes et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

(2014) Danièle Maubon et al.   INTENSIVE CARE MEDICINE

Micafungin is more active against Candida albicans biofilms with high metabolic activity

(2014) L. J. Marcos-Zambrano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fungal Chitin Dampens Inflammation through IL-10 Induction Mediated by NOD2 and TLR9 Activation

(2014) Jeanette Wagener et al.   PLoS Pathogens

Host Defence Against Candida albicans and the Role of Pattern-recognition Receptors

(2013) G Gauglitz et al.   ACTA DERMATO-VENEREOLOGICA

Paradoxical Growth of Candida albicans in the Presence of Caspofungin Is Associated with Multiple Cell Wall Rearrangements and Decreased Virulence

(2013) Cristina Rueda et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current perspectives on echinocandin class drugs

(2011) David S Perlin   Future Microbiology

Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst

(2011) Fernanda Sangalli-Leite et al.   MICROBES AND INFECTION

Echinocandin Antifungal Drugs in Fungal Infections

(2010) Sharon C.-A. Chen et al.   DRUGS

The Candida Th17 response is dependent on mannan- and  -glucan-induced prostaglandin E2

(2010) S. P. Smeekens et al.   INTERNATIONAL IMMUNOLOGY

Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection byCandida albicans

(2009) Thierry Jouault et al.   CELLULAR MICROBIOLOGY

Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates

(2009) Katherine T. Nguyen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins andCandidaspp.

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Caspofungin Modulates Inflammatory Responses toAspergillus fumigatusthrough Stage‐Specific Effects on Fungal β‐Glucan Exposure

(2008) T. M. Hohl et al.   JOURNAL OF INFECTIOUS DISEASES

Dynamic, Morphotype-Specific Candida albicans β-Glucan Exposure during Infection and Drug Treatment

(2008) Robert T. Wheeler et al.   PLoS Pathogens